drugset / Trial / NCT02169154

A Safety Study to Investigate the Skin Irritancy Potential of Diclofenac-Menthol Gel

NCT02169154

Phase 1 Completed 36 enrolled GlaxoSmithKline
RandomizedSingle-groupSingle-blindOther

Summary

This research study is being conducted to investigate the skin irritancy potential of a new medication which contains two active ingredients (diclofenac and menthol) together in a gel formulation and is being developed to treat mild to moderate pain and inflammation, such as acute sport injuries, sprains and strains.

Timeline

Start
2014-06-01
Primary completion
2014-07-01
Completion
2014-07-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Diclofenac Other / unclassified 1 % Topical
Comparator Menthol Small molecule 0.09 % Topical
Comparator Menthol Small molecule 3 % Topical
Comparator Sodium Lauryl Sulfate Small molecule 0.2 % Topical

Indications

No indication recorded.